https://www.selleckchem.com/TGF-beta.html
05). The plasma levels of miR-101-3p and miR-30a-5p were markedly downregulated in patients who experienced hypotension and bradycardia, respectively (P 0.05). MiR-101-3p and miR-140-3p demonstrated a potential discriminatory ability between dexmedetomidine responders and non-responders, with AUC of 0.64 (P 0.05) and 0.77 (P 0.0001), respectively. The AUC of miR-101-3p in distinguishing patients without hypotension was 0.63 (P 0.05). The AUC of miR-30a-5p in distinguishing patients without bradycardia was 0.74 (P 0.05).
Like
Comment
Share
